{
    "General": {
        "Code": "688428",
        "Type": "Common Stock",
        "Name": "InnoCare Pharma Ltd. A",
        "Exchange": "SHG",
        "CurrencyCode": "CNY",
        "CurrencyName": "Renminbi",
        "CurrencySymbol": "\u00a5",
        "CountryName": "China",
        "CountryISO": "CN",
        "OpenFigi": null,
        "ISIN": null,
        "LEI": null,
        "PrimaryTicker": null,
        "CIK": null,
        "EmployerIdNumber": null,
        "FiscalYearEnd": "December",
        "IPODate": null,
        "InternationalDomestic": null,
        "Sector": "Healthcare",
        "Industry": "Biotechnology",
        "GicSector": "Health Care",
        "GicGroup": "Pharmaceuticals, Biotechnology & Life Sciences",
        "GicIndustry": "Biotechnology",
        "GicSubIndustry": "Biotechnology",
        "Description": "InnoCare Pharma Limited, a biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases. It develops Orelabrutinib, an BTK inhibitor to treat patients with relapsed and/or refractory (r/r) chronic lymphocytic leukemia, r/r mantle cell lymphoma, r/r Waldenstrom's macroglobulinemia, r/r marginal zone lymphoma, r/r diffuse large B-cell lymphoma (DLBCL)- MCD, r/r central nervous system lymphoma, combo w/MIL-62, systemic lupus erythematosus, immune thrombocytopenia purpura, multiple sclerosis, and neuromyelitis optica spectrum disorder. The company is also developing ICP-192, a pan-FGFR inhibitor that is in a Phase I/II clinical trial for the treatment of solid tumor patients, including cholangiocarcinoma, and head and neck cancer; ICP-723, a pan-TRK inhibitor, which is in Phase I clinical trial to treat neurotrophic tyrosine receptor kinase fusion positive cancers; ICP-332, a novel tyrosine kinase 2 inhibitor that is in a Phase I clinical trial for the treatment of autoimmune diseases; and ICP-B02, a bispecific antibody for the treatment of lymphoma. In addition, it develops ICP-189 and ICP-B03 for the treatment of solid tumors; ICP-033 to treat liver cancer, renal cell carcinoma, colorectal cancer, and other solid tumors; ICP-488 for the treatment of autoimmune diseases; ICP-B05, an anti-CC chemokine receptor 8 monoclonal antibody for the treatment of various cancers; ICP-248 to treat hematology; and ICP-490 for the treatment of hematology and autoimmune diseases. Further, it offers ICP-B04 (Tafasitamab) to treat DLBCL/hematology. The company has a clinical development collaboration with ArriVent Biopharma, Inc. to evaluate the anti-tumor activity and safety of ICP-189 combined with furmonertinib in patients with advanced non-small cell lung cancer. InnoCare Pharma Limited was incorporated in 2015 and is headquartered in Beijing, China.",
        "Address": null,
        "AddressData": null,
        "Listings": {},
        "Officers": {},
        "Phone": null,
        "WebURL": null,
        "LogoURL": "",
        "FullTimeEmployees": 939,
        "UpdatedAt": "2023-09-02"
    },
    "Highlights": {
        "MarketCapitalization": 10878197760,
        "MarketCapitalizationMln": 10878.1978,
        "EBITDA": -705473920,
        "PERatio": null,
        "PEGRatio": null,
        "WallStreetTargetPrice": 15.23,
        "BookValue": 3.492,
        "DividendShare": 0,
        "DividendYield": 0,
        "EarningsShare": -0.53,
        "EPSEstimateCurrentYear": -0.43,
        "EPSEstimateNextYear": -0.2,
        "EPSEstimateNextQuarter": 0,
        "EPSEstimateCurrentQuarter": 0,
        "MostRecentQuarter": "2023-06-30",
        "ProfitMargin": -1.1459,
        "OperatingMarginTTM": -1.0111,
        "ReturnOnAssetsTTM": -0.0536,
        "ReturnOnEquityTTM": -0.1347,
        "RevenueTTM": 756995328,
        "RevenuePerShareTTM": 0.47,
        "QuarterlyRevenueGrowthYOY": 0.483,
        "GrossProfitTTM": 482006714,
        "DilutedEpsTTM": -0.53,
        "QuarterlyEarningsGrowthYOY": 0
    },
    "Valuation": {
        "TrailingPE": 0,
        "ForwardPE": 0,
        "PriceSalesTTM": 16.9567,
        "PriceBookMRQ": 4.6122,
        "EnterpriseValue": 13486368768,
        "EnterpriseValueRevenue": 13.2965,
        "EnterpriseValueEbitda": -77.8585
    },
    "SharesStats": {
        "SharesOutstanding": 0,
        "SharesFloat": 1142477546,
        "PercentInsiders": 3.3910000000000005,
        "PercentInstitutions": 27.310000000000002,
        "SharesShort": null,
        "SharesShortPriorMonth": null,
        "ShortRatio": null,
        "ShortPercentOutstanding": null,
        "ShortPercentFloat": null
    },
    "Technicals": {
        "Beta": 1.109,
        "52WeekHigh": 16.99,
        "52WeekLow": 8.71,
        "50DayMA": 11.1084,
        "200DayMA": 12.8861,
        "SharesShort": 0,
        "SharesShortPriorMonth": 0,
        "ShortRatio": 0,
        "ShortPercent": 0
    },
    "SplitsDividends": {
        "ForwardAnnualDividendRate": 0,
        "ForwardAnnualDividendYield": 0,
        "PayoutRatio": 0,
        "DividendDate": "0000-00-00",
        "ExDividendDate": "0000-00-00",
        "LastSplitFactor": "",
        "LastSplitDate": "0000-00-00",
        "NumberDividendsByYear": {}
    },
    "Holders": null,
    "InsiderTransactions": {},
    "outstandingShares": {
        "annual": {},
        "quarterly": {}
    },
    "Earnings": {
        "History": {
            "2023-06-30": {
                "reportDate": "2023-08-29",
                "date": "2023-06-30",
                "beforeAfterMarket": "AfterMarket",
                "currency": null,
                "epsActual": null,
                "epsEstimate": null,
                "epsDifference": null,
                "surprisePercent": null
            },
            "2023-03-31": {
                "reportDate": "2023-05-09",
                "date": "2023-03-31",
                "beforeAfterMarket": "AfterMarket",
                "currency": null,
                "epsActual": -0.007,
                "epsEstimate": null,
                "epsDifference": null,
                "surprisePercent": null
            },
            "2022-12-31": {
                "reportDate": "2023-03-27",
                "date": "2022-12-31",
                "beforeAfterMarket": "AfterMarket",
                "currency": null,
                "epsActual": -0.08,
                "epsEstimate": -0.05,
                "epsDifference": -0.03,
                "surprisePercent": -60
            },
            "2022-09-30": {
                "reportDate": "2022-10-12",
                "date": "2022-09-30",
                "beforeAfterMarket": "BeforeMarket",
                "currency": null,
                "epsActual": -0.2226,
                "epsEstimate": null,
                "epsDifference": null,
                "surprisePercent": null
            }
        },
        "Trend": {
            "2024-12-31": {
                "date": "2024-12-31",
                "period": "+1y",
                "growth": "0.5350",
                "earningsEstimateAvg": "-0.2000",
                "earningsEstimateLow": "-0.3900",
                "earningsEstimateHigh": "-0.0100",
                "earningsEstimateYearAgoEps": "-0.4300",
                "earningsEstimateNumberOfAnalysts": "2.0000",
                "earningsEstimateGrowth": "0.5350",
                "revenueEstimateAvg": "1444460000.00",
                "revenueEstimateLow": "1135110000.00",
                "revenueEstimateHigh": "1729270000.00",
                "revenueEstimateYearAgoEps": null,
                "revenueEstimateNumberOfAnalysts": "3.00",
                "revenueEstimateGrowth": "0.5230",
                "epsTrendCurrent": "-0.2000",
                "epsTrend7daysAgo": "-0.2000",
                "epsTrend30daysAgo": "-0.2000",
                "epsTrend60daysAgo": "-0.2000",
                "epsTrend90daysAgo": "-0.2000",
                "epsRevisionsUpLast7days": "0.0000",
                "epsRevisionsUpLast30days": "0.0000",
                "epsRevisionsDownLast7days": null,
                "epsRevisionsDownLast30days": "0.0000"
            },
            "2023-12-31": {
                "date": "2023-12-31",
                "period": "0y",
                "growth": "0.2830",
                "earningsEstimateAvg": "-0.4300",
                "earningsEstimateLow": "-0.6100",
                "earningsEstimateHigh": "-0.2500",
                "earningsEstimateYearAgoEps": "-0.6000",
                "earningsEstimateNumberOfAnalysts": "2.0000",
                "earningsEstimateGrowth": "0.2830",
                "revenueEstimateAvg": "948360000.00",
                "revenueEstimateLow": "824330000.00",
                "revenueEstimateHigh": "1053000000.00",
                "revenueEstimateYearAgoEps": null,
                "revenueEstimateNumberOfAnalysts": "3.00",
                "revenueEstimateGrowth": "0.5160",
                "epsTrendCurrent": "-0.4300",
                "epsTrend7daysAgo": "-0.4300",
                "epsTrend30daysAgo": "-0.4300",
                "epsTrend60daysAgo": "-0.4300",
                "epsTrend90daysAgo": "-0.4300",
                "epsRevisionsUpLast7days": "0.0000",
                "epsRevisionsUpLast30days": "0.0000",
                "epsRevisionsDownLast7days": null,
                "epsRevisionsDownLast30days": "0.0000"
            },
            "2023-06-30": {
                "date": "2023-06-30",
                "period": "+1q",
                "growth": null,
                "earningsEstimateAvg": "0.0000",
                "earningsEstimateLow": "0.0000",
                "earningsEstimateHigh": "0.0000",
                "earningsEstimateYearAgoEps": null,
                "earningsEstimateNumberOfAnalysts": "0.0000",
                "earningsEstimateGrowth": null,
                "revenueEstimateAvg": "0.00",
                "revenueEstimateLow": "0.00",
                "revenueEstimateHigh": "0.00",
                "revenueEstimateYearAgoEps": null,
                "revenueEstimateNumberOfAnalysts": "0.00",
                "revenueEstimateGrowth": null,
                "epsTrendCurrent": "0.0000",
                "epsTrend7daysAgo": "0.0000",
                "epsTrend30daysAgo": "0.0000",
                "epsTrend60daysAgo": "0.0000",
                "epsTrend90daysAgo": "0.0000",
                "epsRevisionsUpLast7days": "0.0000",
                "epsRevisionsUpLast30days": "0.0000",
                "epsRevisionsDownLast7days": null,
                "epsRevisionsDownLast30days": "0.0000"
            },
            "2023-03-31": {
                "date": "2023-03-31",
                "period": "0q",
                "growth": null,
                "earningsEstimateAvg": "0.0000",
                "earningsEstimateLow": "0.0000",
                "earningsEstimateHigh": "0.0000",
                "earningsEstimateYearAgoEps": null,
                "earningsEstimateNumberOfAnalysts": "0.0000",
                "earningsEstimateGrowth": null,
                "revenueEstimateAvg": "0.00",
                "revenueEstimateLow": "0.00",
                "revenueEstimateHigh": "0.00",
                "revenueEstimateYearAgoEps": null,
                "revenueEstimateNumberOfAnalysts": "0.00",
                "revenueEstimateGrowth": null,
                "epsTrendCurrent": "0.0000",
                "epsTrend7daysAgo": "0.0000",
                "epsTrend30daysAgo": "0.0000",
                "epsTrend60daysAgo": "0.0000",
                "epsTrend90daysAgo": "0.0000",
                "epsRevisionsUpLast7days": "0.0000",
                "epsRevisionsUpLast30days": "0.0000",
                "epsRevisionsDownLast7days": null,
                "epsRevisionsDownLast30days": "0.0000"
            },
            "2022-12-31": {
                "date": "2022-12-31",
                "period": "0y",
                "growth": null,
                "earningsEstimateAvg": "-0.5000",
                "earningsEstimateLow": "-0.5300",
                "earningsEstimateHigh": "-0.4500",
                "earningsEstimateYearAgoEps": null,
                "earningsEstimateNumberOfAnalysts": "3.0000",
                "earningsEstimateGrowth": null,
                "revenueEstimateAvg": "625404000.00",
                "revenueEstimateLow": "551850000.00",
                "revenueEstimateHigh": "646180000.00",
                "revenueEstimateYearAgoEps": null,
                "revenueEstimateNumberOfAnalysts": "3.00",
                "revenueEstimateGrowth": null,
                "epsTrendCurrent": "-0.5000",
                "epsTrend7daysAgo": "-0.5000",
                "epsTrend30daysAgo": "-0.5000",
                "epsTrend60daysAgo": "-0.5000",
                "epsTrend90daysAgo": "0.0000",
                "epsRevisionsUpLast7days": "0.0000",
                "epsRevisionsUpLast30days": "0.0000",
                "epsRevisionsDownLast7days": null,
                "epsRevisionsDownLast30days": "0.0000"
            }
        },
        "Annual": {
            "2023-06-30": {
                "date": "2023-06-30",
                "epsActual": -0.007
            },
            "2022-12-31": {
                "date": "2022-12-31",
                "epsActual": -0.3026
            }
        }
    },
    "Financials": {
        "Balance_Sheet": {
            "currency_symbol": null,
            "quarterly": {},
            "yearly": {}
        },
        "Cash_Flow": {
            "currency_symbol": null,
            "quarterly": {},
            "yearly": {}
        },
        "Income_Statement": {
            "currency_symbol": null,
            "quarterly": {},
            "yearly": {}
        }
    }
}